Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...

This partnership aims to extend The A-List Clinic’s reach, making it easier for people in the entertainment industry to learn ...

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...